GB916455A - Non-toxic antigens and process for producing same - Google Patents
Non-toxic antigens and process for producing sameInfo
- Publication number
- GB916455A GB916455A GB25289/61A GB2528961A GB916455A GB 916455 A GB916455 A GB 916455A GB 25289/61 A GB25289/61 A GB 25289/61A GB 2528961 A GB2528961 A GB 2528961A GB 916455 A GB916455 A GB 916455A
- Authority
- GB
- United Kingdom
- Prior art keywords
- toxic
- protein
- antigen
- producing same
- synthetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
A synthetic non-toxic antigen, which when used to inoculate a living organism is effective in producing antibodies against Gram-negative bacteria, has as a constituent of a determinant group thereof at least one 3,6-didesoxyhexose coupled to a protein which is physiologically acceptable by the organism to be inoculated. The 3,6-didesoxy-hexose may be abequose, colitose, tyvelose, paratose or ascarylose, and the protein may be serum albumin or serum globulin. The synthetic antigen may be applied together with a non-toxic pharmaceutical carrier such as a sterile isotonic aqueous solution containing a preservative. Specification 725,938 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH793560A CH396316A (en) | 1960-07-12 | 1960-07-12 | Process for the manufacture of vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
GB916455A true GB916455A (en) | 1963-01-23 |
Family
ID=4332624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB25289/61A Expired GB916455A (en) | 1960-07-12 | 1961-07-12 | Non-toxic antigens and process for producing same |
Country Status (4)
Country | Link |
---|---|
CH (1) | CH396316A (en) |
ES (1) | ES268958A1 (en) |
FR (1) | FR1175M (en) |
GB (1) | GB916455A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0123114A1 (en) * | 1983-03-28 | 1984-10-31 | Miles Laboratories, Inc. | Urea-linked immunogens, antibodies, and preparative method |
EP0097407B1 (en) * | 1982-06-22 | 1987-05-13 | Rijksuniversiteit Utrecht | Vaccines against diseases causing bacteria with capsular polysaccharides and process of preparing them |
EP0306607A1 (en) * | 1983-03-14 | 1989-03-15 | Miles Inc. | Vaccines for gram-negative bacteria |
-
1960
- 1960-07-12 CH CH793560A patent/CH396316A/en unknown
-
1961
- 1961-05-26 FR FR862944A patent/FR1175M/en not_active Expired
- 1961-07-10 ES ES0268958A patent/ES268958A1/en not_active Expired
- 1961-07-12 GB GB25289/61A patent/GB916455A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0097407B1 (en) * | 1982-06-22 | 1987-05-13 | Rijksuniversiteit Utrecht | Vaccines against diseases causing bacteria with capsular polysaccharides and process of preparing them |
EP0306607A1 (en) * | 1983-03-14 | 1989-03-15 | Miles Inc. | Vaccines for gram-negative bacteria |
EP0123114A1 (en) * | 1983-03-28 | 1984-10-31 | Miles Laboratories, Inc. | Urea-linked immunogens, antibodies, and preparative method |
Also Published As
Publication number | Publication date |
---|---|
FR1175M (en) | 1962-03-12 |
CH396316A (en) | 1965-07-31 |
ES268958A1 (en) | 1961-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1257263A (en) | ||
FI103976B1 (en) | Method for Diagnosis of Insulin Dependent Diabetes Mellitus (IDDM) in vitro, and Equipment and Polypeptide | |
ZA872166B (en) | Synthetic htlv-iii peptides,compositions and uses thereof | |
DK609985A (en) | ADHESIN ANTIGENES, ANTIBODIES AGAINST THESE AND DNA FRAGMENTS WHICH ENCOD THE ANTIGENES | |
SE8202012L (en) | HUMAN INTERFERON-RELATED PEPTIDES, ANTIGENS, ANTIBODIES AND PROCEDURES FOR PRODUCING THEREOF | |
DE69017149D1 (en) | Synthetic peptides useful as universal carriers for the production of immunogenic conjugates and their use in the development of synthetic vaccines. | |
ATE866T1 (en) | IMMUNE GERMINAL GLOBULIN (ISG) PREPARATIONS AND PROCESSES FOR THEIR MANUFACTURE. | |
NZ221065A (en) | Conjugates of antibodies and toxins with sulphur-containing linking groups | |
KR900005986A (en) | Use of zinc hydroxide or iron hydroxide as adjuvant in antigen solution, and antigen solution containing such adjuvant | |
SE7608174L (en) | PROCEDURE FOR PREPARING ANTISERUM | |
GB916455A (en) | Non-toxic antigens and process for producing same | |
ATE269904T1 (en) | TRANSPORT AND EXPRESSION OF A HYBRID SURFACE PROTEIN ON THE SURFACE OF GRAMP POSITIVE BACTERIA | |
PT93178A (en) | ANTICANCEROSO PROTEIN AGENT | |
ATE2049T1 (en) | MEANS OF THERAPY OF IMMUNOCOMPLEX DISEASES. | |
JPS6461499A (en) | Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof | |
ES2074983T3 (en) | PROCEDURE FOR THE ISOLATION OF BASAL MEMBRANE PROTEINS FROM HUMAN AND ANIMAL TISSUES. | |
JPS55141452A (en) | Synthetic polypeptide | |
ATE139701T1 (en) | COMPOSITION FOR REDUCING THE SIDE EFFECTS OF A MEDICINAL PRODUCT | |
Ashcroft et al. | Antibody responses to vaccination of British Guiana schoolchildren with heat-killed phenolized and acetone-killed lyophilized typhoid vaccines | |
NO864382D0 (en) | MEASURES FOR IMPROVING PROTEIN ABSORPTION. | |
NL971002I1 (en) | Process for the preparation of 4-amino-5-chloro-1-phenylpyridazone- (6). | |
SE8703453D0 (en) | PREPARATION CONTAINING HIGH-MOLECULATED BACTERIAL PROTEIN, ANTIBODY PREPARATION DIRECTED, AND USE OF PREPARATIONS | |
KR890009417A (en) | Method for producing monoclonal antibody and method of using the same | |
SE8101728L (en) | TRANSFORMATION AT AMIDER | |
KR860008779A (en) | Method for producing antibody forming compound |